Institution statistics

ANTAROS MEDICAL AB -  

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 15.000.000 250.000 1
2017 0 27.797.881 797.300 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
PFIZER LIMITED3
ACADEMISCH ZIEKENHUIS GRONINGEN2
NOVARTIS PHARMA2
NOVO NORDISK2
SANOFIAVENTIS DEUTSCHLAND2
TAKEDA DEVELOPMENT CENTRE EUROPE2
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE2
ABBVIE DEUTSCHLAND GMBH & CO KG1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ALLERGAN LIMITED1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTRAZENECA AB1
BAYER1
BAYER PHARMA1
BIOXYDYN LIMITED1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BRISTOLMYERS SQUIBB COMPANY CORP1
BRUKER BIOSPIN MRI1
CHALMERS TEKNISKA HOEGSKOLA AB1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ECHOSENS1
ELI LILLY AND COMPANY LIMITED1
ELLEGAARD GOTTINGEN MINIPIGS AS1
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON1
EUROPEAN ASSOCIATION FOR THE STUDYOF THE LIVER1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
EXALENZ BIOSCIENCE1
F HOFFMANNLA ROCHE1
FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA1
FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA1
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
GE HEALTHCARE LIMITED1
GENFIT1
GILEAD SCIENCES INC1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
HISTOINDEX PTE1
IMAGINAB INC1
INST CARDIOMETABOLISME NUTRITION ICAN1
INTERCEPT PHARMA EUROPE1
IXSCIENT LIMITED1
JANSSEN PHARMACEUTICA NV1
LAWRENCIUM LEGAL BV1
LINKOPINGS UNIVERSITET1
LUNDS UNIVERSITET1
LUXEMBOURG INSTITUTE OF HEALTH1
MEDIZINISCHE UNIVERSITAET WIEN1
MERCK SHARP & DOHME CORP1
NORDIC BIOSCIENCE1
NORDIC BIOSCIENCE COMPOUND DEVELOPMENT1
ONE WAY LIVER SL1
OREBRO UNIVERSITY1
PERSPECTUM DIAGNOSTICS1
RESEARCH TRIANGLE INSTITUTE1
RESOUNDANT INC1
SERVICIO ANDALUZ DE SALUD1
SOMALOGIC INC1
STICHTING KATHOLIEKE UNIVERSITEIT1
STICHTING LYGATURE1
STICHTING VUMC1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE UNIVERSITY OF MANCHESTER1
THE UNIVERSITY OF NOTTINGHAM1
THE UNIVERSITY OF SHEFFIELD1
TRULY LABS AB1
TTOPSTART BV1
UNIVERSITA CATTOLICA DEL SACRO CUORE1
UNIVERSITA DEGLI STUDI DI MILANO1
UNIVERSITA DEGLI STUDI DI PALERMO1
UNIVERSITA DEGLI STUDI DI TORINO1
UNIVERSITAET BERN1
UNIVERSITAETSKLINIKUM AACHEN1
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT1
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1
UNIVERSITAIR ZIEKENHUIS ANTWERPEN1
UNIVERSITE D'ANGERS1
UNIVERSITE DE BOURGOGNE1
UNIVERSITY OF BIRMINGHAM1
UNIVERSITY OF HELSINKI1
UNIVERSITY OF LEEDS1
UNIVERSITY OF NEWCASTLE UPON TYNE1
VIB1
VRIJE UNIVERSITEIT BRUSSEL1
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER1
Constancy:

Total number of partners:96

Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 93

Frequent / Rare Partner Ratio: 0.03

Diversity:

Subjects:
Subject:No:
Diversity index:0
Categories:
Category:No:

Project overview:

Start dateProjectacronymrolefundingpartners
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imageparticipant15.000.00022
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-01-01Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 IB4SD-TRISTANparticipant12.000.00021
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum